The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A Zero Based Budgeting Case Study Analysis distills methods, results, and lessons to help you optimize your own zero-based plan.
21,876 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A surge of early arrivals has prompted airports to change guidance, arguing that arriving too early can slow lines fo...
Longbridge's Q1 results set a quarterly high and eclipsed its 2025 full-year profit, highlighting strong reverse-mort...
SanDisk is leading a powerful memory-chip rally, jumping 558% this year as AI-driven data-center demand reshapes expe...
Meta Platforms is down about 11% in a month as Alphabet climbs roughly 16%, driven by AI-driven revenue signals. The ...
Rising Treasury yields are lifting single premium immediate annuities, offering guaranteed lifetime income for retire...
Berkshire Hathaway's Bank of America stake remains a defining part of its portfolio, even as the company reshapes its...
Jeff Immelt debuts a Substack column to speak openly about GE’s legacy and his life after the helm. The move mirrors ...
SpaceX priced its IPO at a fixed $135 per share, aiming to raise roughly $75 billion and valuing the company around $...
An overlooked cleantech fund just delivered a powerful start to 2026, posting double-digit gains year-to-date and ecl...
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
A Tron-based USDT flow led Tether to freeze about $72 million in USDT amid suspected laundering, with no public hack ...